NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Compass Diversified Holdings (NYSE: CODI) between May 1, 2024, and May 7, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Compass securities you may be entitled to compensation without payment of any out of pocket fees or costs through a c ...

Core Viewpoint - Rosen Law Firm is reminding investors who sold or held shares of Cerevel Therapeutics Holdings, Inc. during a specified period about their potential entitlement to compensation through a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes those who held shares as of January 8, 2024, and those who sold shares around Bain Capital's purchase on October 16, 2023 [1]. - Investors may join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move to serve as lead plaintiff by June 3, 2025 [3]. Group 2: Case Allegations - The lawsuit alleges that during the class period, Cerevel's controlling shareholders made false and misleading statements related to a secondary stock offering on October 16, 2023, and a proxy statement on January 18, 2024 [5]. - The secondary stock offering was purportedly designed to allow Bain Capital to increase its stake in Cerevel at a discounted price before AbbVie Inc.'s acquisition announcement [5]. - Following the offering, AbbVie announced its acquisition of Cerevel for $45 per share, nearly double the offering price, resulting in Bain Capital receiving over $120 million in windfall profits [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019 and has been ranked highly in securities class action settlements since 2013 [4].

NEW YORK, May 27, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than July 21, 2025.So What: If you purchased DoubleVerify common stock during the Class Period you may be entitled to compen ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Everus Construction Group, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who acquired Everus Construction common stock between October 31, 2024, and February 11, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 3, 2025 [3]. Group 2: Case Background - The lawsuit alleges that during the Class Period, defendants made false or misleading statements regarding Everus Construction's backlog conversion cycle, which had become elongated due to larger, more complex projects [5]. - It is claimed that as a result of these issues, revenue recognition for Everus Construction would be delayed, and positive statements about the company's business and prospects were materially misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Compass Diversified Holdings during the specified class period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - The class period for the Compass securities class action is from May 1, 2024, to May 7, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [3][6]. Group 2: Case Allegations - The lawsuit alleges that Compass's subsidiary, Lugano Holdings, Inc., had unrecorded financing arrangements and irregularities in its financial reporting [5]. - It is claimed that these irregularities rendered Compass's overall financial statements unreliable and necessitated a restatement [5]. - The lawsuit also states that Compass failed to maintain adequate internal controls over its financial statements, leading to materially false and misleading public statements [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Ibotta, Inc. securities about the upcoming lead plaintiff deadline in a securities class action related to Ibotta's IPO and subsequent performance issues [1][5]. Group 1: Class Action Details - The class action pertains to securities purchased pursuant to Ibotta's registration statement during the class period from April 18, 2024, to February 26, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must be appointed by June 16, 2025, to represent other class members in the litigation [3]. Group 2: Allegations Against Ibotta - The lawsuit alleges that Ibotta made false or misleading statements regarding its contract with Kroger and the accuracy of its data measurement system [5]. - It is claimed that Ibotta's business mix had shifted, resulting in decreased revenue, and that the company had "exhausted" its clients' budgets, negatively impacting revenue forecasts for Q4 2024 and Q1 2025 [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Actinium Pharmaceuticals, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on May 27, 2025 [1]. Group 1: Class Action Details - Investors who purchased Actinium securities between October 31, 2022, and August 2, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lawsuit alleges that during the Class Period, Actinium made false or misleading statements regarding its Iomab-B Biologics License Application, which may not meet FDA guidelines [5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [4]. - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been recognized as a leader in securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Bitfarms Ltd. securities during the specified class period of their potential entitlement to compensation through a class action lawsuit [1][4]. Group 1: Class Action Details - The class period for the Bitfarms securities is from March 21, 2023, to December 9, 2024 [1]. - Investors can join the class action by submitting a form or contacting the law firm directly [2][5]. - A lead plaintiff must be appointed by July 8, 2025, to represent other class members in the litigation [2]. Group 2: Allegations Against Bitfarms - The lawsuit alleges that Bitfarms made false or misleading statements and failed to disclose significant issues regarding its internal controls over financial reporting [4]. - Specific allegations include misclassification of cash flows from the sale of digital assets and overstating the remediation of internal control weaknesses [4]. - The inaccuracies in financial statements are said to have caused investor damages when the true information became public [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [3]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in representing investor interests [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased NET Power Inc. securities between June 9, 2023, and March 7, 2025, of the upcoming lead plaintiff deadline on June 17, 2025, for a class action lawsuit related to misleading statements made by the company [1][2]. Group 1: Class Action Details - Investors who bought NET Power securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by June 17, 2025 [2]. - The lawsuit alleges that NET Power made false and misleading statements regarding the completion and costs of Project Permian, which is critical to the company's operations [3]. Group 2: Allegations Against NET Power - The lawsuit claims that NET Power was unlikely to complete Project Permian on schedule and that the project would be significantly more expensive than previously stated due to supply chain issues and site-specific challenges [3]. - It is asserted that the company's projections regarding the time and capital needed for Project Permian were unrealistic, which could negatively impact NET Power's business and financial results [3]. - The lawsuit contends that the misleading public statements made by NET Power resulted in investor damages when the true situation became known [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms in securities class action settlements [4]. - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, further establishing the firm's credibility in handling such cases [4].

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...